Last reviewed · How we verify
Rheumatism
Approved treatments
- Bay F 4975
Acemetacin works by inhibiting the enzyme lactoylglutathione lyase, which is involved in the breakdown of certain inflammatory mediators.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Rheumatism patent landscape — cliff calendar, originator estates, attackable patents
- Rheumatism treatment landscape brief
- Rheumatism treatment updates RSS
Frequently asked questions about Rheumatism
What drugs treat Rheumatism?
Tracked treatments include Bay F 4975.
What is the treatment for Rheumatism?
Standard treatment for Rheumatism includes Bay F 4975. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Rheumatism patent cliff · Rheumatism CI report
- Treatment: Bay F 4975
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing